ID MC5R_HUMAN Reviewed; 325 AA. AC P33032; B0YJ34; Q502V1; DT 01-OCT-1993, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1995, sequence version 3. DT 27-MAR-2024, entry version 194. DE RecName: Full=Melanocortin receptor 5; DE Short=MC5-R; DE AltName: Full=MC-2; GN Name=MC5R; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC TISSUE=Placenta; RX PubMed=8396929; DOI=10.1006/bbrc.1993.2125; RA Chhajlani V., Muceniece R., Wikberg J.E.S.; RT "Molecular cloning of a novel human melanocortin receptor."; RL Biochem. Biophys. Res. Commun. 195:866-873(1993). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=8179577; DOI=10.1006/bbrc.1994.1550; RA Griffon N., Mignon V., Facchinetti P., Diaz J., Schwartz J.-C., RA Sokoloff P.; RT "Molecular cloning and characterization of the rat fifth melanocortin RT receptor."; RL Biochem. Biophys. Res. Commun. 200:1007-1014(1994). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC TISSUE=Placenta; RX PubMed=7739752; DOI=10.1007/bf00995160; RA Fathi Z., Iben L.G., Parker E.M.; RT "Cloning, expression, and tissue distribution of a fifth melanocortin RT receptor subtype."; RL Neurochem. Res. 20:107-113(1995). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Kopatz S.A., Aronstam R.S., Sharma S.V.; RT "cDNA clones of human proteins involved in signal transduction sequenced by RT the Guthrie cDNA resource center (www.cdna.org)."; RL Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RG NHLBI resequencing and genotyping service (RS&G); RL Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-209. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP MUTAGENESIS OF GLN-235 AND ARG-272. RX PubMed=9240466; DOI=10.1006/bbrc.1997.6994; RA Fraendberg P.-A., Xu X., Chhajlani V.; RT "Glutamine235 and arginine272 in human melanocortin 5 receptor determines RT its low affinity to MSH."; RL Biochem. Biophys. Res. Commun. 236:489-492(1997). RN [9] RP VARIANT LEU-209. RX PubMed=11286624; DOI=10.1046/j.0022-202x.2001.01286.x; RA Hatta N., Dixon C., Ray A.J., Phillips S.R., Cunliffe W.J., Dale M., RA Todd C., Meggit S., Birch-MacHin M.A., Rees J.L.; RT "Expression, candidate gene, and population studies of the melanocortin 5 RT receptor."; RL J. Invest. Dermatol. 116:564-570(2001). CC -!- FUNCTION: Receptor for MSH (alpha, beta and gamma) and ACTH. The CC activity of this receptor is mediated by G proteins which activate CC adenylate cyclase. This receptor is a possible mediator of the CC immunomodulation properties of melanocortins. CC -!- INTERACTION: CC P33032; Q8TCY5: MRAP; NbExp=2; IntAct=EBI-9538507, EBI-9538727; CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. CC -!- TISSUE SPECIFICITY: Expressed in the brain but not in the melanoma CC cells. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC -!- WEB RESOURCE: Name=Wikipedia; Note=Melanocortin receptor entry; CC URL="https://en.wikipedia.org/wiki/Melanocortin_receptor"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Z25470; CAA80962.1; -; Genomic_DNA. DR EMBL; L27080; AAA59566.1; -; Genomic_DNA. DR EMBL; U08353; AAB60376.1; -; Genomic_DNA. DR EMBL; AY268429; AAP23196.1; -; Genomic_DNA. DR EMBL; EF444993; ACA06012.1; -; Genomic_DNA. DR EMBL; CH471113; EAX01504.1; -; Genomic_DNA. DR EMBL; BC069153; AAH69153.1; -; mRNA. DR EMBL; BC069545; AAH69545.1; -; mRNA. DR EMBL; BC095531; AAH95531.1; -; mRNA. DR CCDS; CCDS11868.1; -. DR PIR; JC5592; JC5592. DR PIR; JN0764; JN0764. DR RefSeq; NP_005904.1; NM_005913.2. DR PDB; 8INR; EM; 2.73 A; R=2-325. DR PDB; 8IOD; EM; 2.59 A; R=2-325. DR PDBsum; 8INR; -. DR PDBsum; 8IOD; -. DR AlphaFoldDB; P33032; -. DR EMDB; EMD-35601; -. DR EMDB; EMD-35616; -. DR SMR; P33032; -. DR BioGRID; 110331; 1. DR DIP; DIP-48792N; -. DR IntAct; P33032; 2. DR STRING; 9606.ENSP00000468086; -. DR BindingDB; P33032; -. DR ChEMBL; CHEMBL4608; -. DR DrugBank; DB11653; Bremelanotide. DR DrugCentral; P33032; -. DR GuidetoPHARMACOLOGY; 286; -. DR GlyCosmos; P33032; 4 sites, No reported glycans. DR GlyGen; P33032; 4 sites. DR iPTMnet; P33032; -. DR PhosphoSitePlus; P33032; -. DR BioMuta; MC5R; -. DR DMDM; 729996; -. DR PaxDb; 9606-ENSP00000318077; -. DR PeptideAtlas; P33032; -. DR Antibodypedia; 7155; 451 antibodies from 37 providers. DR DNASU; 4161; -. DR Ensembl; ENST00000324750.5; ENSP00000318077.3; ENSG00000176136.6. DR Ensembl; ENST00000589410.2; ENSP00000468086.2; ENSG00000176136.6. DR GeneID; 4161; -. DR KEGG; hsa:4161; -. DR MANE-Select; ENST00000589410.2; ENSP00000468086.2; NM_005913.3; NP_005904.1. DR UCSC; uc010xaf.3; human. DR AGR; HGNC:6933; -. DR CTD; 4161; -. DR DisGeNET; 4161; -. DR GeneCards; MC5R; -. DR HGNC; HGNC:6933; MC5R. DR HPA; ENSG00000176136; Tissue enhanced (epididymis, lymphoid tissue). DR MIM; 600042; gene. DR neXtProt; NX_P33032; -. DR OpenTargets; ENSG00000176136; -. DR PharmGKB; PA30677; -. DR VEuPathDB; HostDB:ENSG00000176136; -. DR eggNOG; KOG3656; Eukaryota. DR GeneTree; ENSGT01030000234510; -. DR HOGENOM; CLU_009579_13_0_1; -. DR InParanoid; P33032; -. DR OMA; VYYESTY; -. DR OrthoDB; 4160596at2759; -. DR PhylomeDB; P33032; -. DR TreeFam; TF332646; -. DR PathwayCommons; P33032; -. DR Reactome; R-HSA-375276; Peptide ligand-binding receptors. DR Reactome; R-HSA-418555; G alpha (s) signalling events. DR SignaLink; P33032; -. DR SIGNOR; P33032; -. DR BioGRID-ORCS; 4161; 8 hits in 1135 CRISPR screens. DR GeneWiki; Melanocortin_5_receptor; -. DR GenomeRNAi; 4161; -. DR Pharos; P33032; Tchem. DR PRO; PR:P33032; -. DR Proteomes; UP000005640; Chromosome 18. DR RNAct; P33032; Protein. DR Bgee; ENSG00000176136; Expressed in primordial germ cell in gonad and 39 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IDA:HPA. DR GO; GO:0042562; F:hormone binding; IEA:Ensembl. DR GO; GO:0004977; F:melanocortin receptor activity; IBA:GO_Central. DR GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:BHF-UCL. DR GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc. DR GO; GO:0019222; P:regulation of metabolic process; IBA:GO_Central. DR CDD; cd15354; 7tmA_MC5R; 1. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR InterPro; IPR001908; MC3-5R. DR InterPro; IPR000621; Melancort_rcpt_5. DR InterPro; IPR001671; Melcrt_ACTH_rcpt. DR PANTHER; PTHR22750; G-PROTEIN COUPLED RECEPTOR; 1. DR PANTHER; PTHR22750:SF5; MELANOCORTIN RECEPTOR 5; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR00237; GPCRRHODOPSN. DR PRINTS; PR00534; MCRFAMILY. DR PRINTS; PR00535; MELNOCORTINR. DR PRINTS; PR01063; MELNOCORTN5R. DR SMART; SM01381; 7TM_GPCR_Srsx; 1. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. DR Genevisible; P33032; HS. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; G-protein coupled receptor; Glycoprotein; KW Lipoprotein; Membrane; Palmitate; Receptor; Reference proteome; Transducer; KW Transmembrane; Transmembrane helix. FT CHAIN 1..325 FT /note="Melanocortin receptor 5" FT /id="PRO_0000069728" FT TOPO_DOM 1..37 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 38..61 FT /note="Helical; Name=1" FT /evidence="ECO:0000255" FT TOPO_DOM 62..73 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 74..97 FT /note="Helical; Name=2" FT /evidence="ECO:0000255" FT TOPO_DOM 98..114 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 115..138 FT /note="Helical; Name=3" FT /evidence="ECO:0000255" FT TOPO_DOM 139..155 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 156..179 FT /note="Helical; Name=4" FT /evidence="ECO:0000255" FT TOPO_DOM 180..186 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 187..211 FT /note="Helical; Name=5" FT /evidence="ECO:0000255" FT TOPO_DOM 212..239 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 240..265 FT /note="Helical; Name=6" FT /evidence="ECO:0000255" FT TOPO_DOM 266..273 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 274..297 FT /note="Helical; Name=7" FT /evidence="ECO:0000255" FT TOPO_DOM 298..325 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT LIPID 311 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000255" FT LIPID 312 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000255" FT CARBOHYD 2 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 15 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 20 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 28 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VARIANT 209 FT /note="F -> L (in dbSNP:rs2236700)" FT /evidence="ECO:0000269|PubMed:11286624, FT ECO:0000269|PubMed:15489334" FT /id="VAR_013128" FT MUTAGEN 235 FT /note="Q->K: 10% increase of binding to alpha-MSH." FT /evidence="ECO:0000269|PubMed:9240466" FT MUTAGEN 272 FT /note="R->C: 690% increase of binding to alpha-MSH." FT /evidence="ECO:0000269|PubMed:9240466" FT CONFLICT 149 FT /note="R -> A (in Ref. 2; AAA59566)" FT /evidence="ECO:0000305" FT CONFLICT 221..234 FT /note="ALPGASSARQRTSM -> LCPGPALRGRGPAW (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 297 FT /note="F -> Y (in Ref. 2; AAA59566)" FT /evidence="ECO:0000305" FT HELIX 40..43 FT /evidence="ECO:0007829|PDB:8IOD" FT HELIX 45..59 FT /evidence="ECO:0007829|PDB:8IOD" FT TURN 60..63 FT /evidence="ECO:0007829|PDB:8IOD" FT STRAND 64..66 FT /evidence="ECO:0007829|PDB:8IOD" FT HELIX 70..100 FT /evidence="ECO:0007829|PDB:8IOD" FT HELIX 108..145 FT /evidence="ECO:0007829|PDB:8IOD" FT STRAND 148..150 FT /evidence="ECO:0007829|PDB:8IOD" FT TURN 151..153 FT /evidence="ECO:0007829|PDB:8IOD" FT HELIX 156..179 FT /evidence="ECO:0007829|PDB:8IOD" FT HELIX 184..219 FT /evidence="ECO:0007829|PDB:8IOD" FT STRAND 220..222 FT /evidence="ECO:0007829|PDB:8IOD" FT HELIX 234..246 FT /evidence="ECO:0007829|PDB:8IOD" FT TURN 247..251 FT /evidence="ECO:0007829|PDB:8IOD" FT HELIX 253..260 FT /evidence="ECO:0007829|PDB:8IOD" FT TURN 261..263 FT /evidence="ECO:0007829|PDB:8IOD" FT HELIX 268..274 FT /evidence="ECO:0007829|PDB:8IOD" FT HELIX 277..295 FT /evidence="ECO:0007829|PDB:8IOD" FT STRAND 297..299 FT /evidence="ECO:0007829|PDB:8IOD" FT HELIX 300..311 FT /evidence="ECO:0007829|PDB:8IOD" SQ SEQUENCE 325 AA; 36601 MW; 8BEC17E1BDA059BB CRC64; MNSSFHLHFL DLNLNATEGN LSGPNVKNKS SPCEDMGIAV EVFLTLGVIS LLENILVIGA IVKNKNLHSP MYFFVCSLAV ADMLVSMSSA WETITIYLLN NKHLVIADAF VRHIDNVFDS MICISVVASM CSLLAIAVDR YVTIFYALRY HHIMTARRSG AIIAGIWAFC TGCGIVFILY SESTYVILCL ISMFFAMLFL LVSLYIHMFL LARTHVKRIA ALPGASSARQ RTSMQGAVTV TMLLGVFTVC WAPFFLHLTL MLSCPQNLYC SRFMSHFNMY LILIMCNSVM DPLIYAFRSQ EMRKTFKEII CCRGFRIACS FPRRD //